LI ZHILIN (CEO and interim CFO) received a stock award from CHINA PHARMA HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/19/2023ACC: 0001013762-23-005114
DirectorOfficer10% Owner· CEO and interim CFO
Since Dec 2020
+13.76M
Net shares
Net buyer
$1.93M
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
13.76M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+13.76M
Price / share
$0.14
Trade value
$1.93M
% of position
996.2%
9/29/2023
1.38M→15.14M
Total
Net shares
+13.76M
Net value
$1.93M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/29/2023 | A · Award | +13.76M | $0.14 | $1.93M | 996.2% | 1.38M | 15.14M |
| Total | +13.76M | $1.93M | ||||||
Derivative Transactions0
No derivative transactions reported